Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Report forecasts huge increase in veterinary medicine market
The global veterinary medicine market is expected to grow at a rate of 8.1 per cent over the next five years.
Increase in popularity of companion animals a key driver 

The global veterinary medicine market is expected to grow at a rate of 8.1 per cent over the next five years, according to a report published by marketresearchfuture.com

The Veterinary Medicine Market Report - Global Forecast to 2023 found that an increase in popularity of companion animals will be the biggest driver of the market. Increasing animal diseases and government welfare initiatives are also expected to provide a significant boost.

Veterinary medicine is widely practised across the globe due to an increasing number of pet adoptions, rising veterinary expenditure and rising demand for pet insurance. Some of the key players include Zoetis, Inc, Eli Lilly and Company and Bayer Healthcare AG.

The veterinary medicines market is segmented into five regions - America, Europe, Asia Pacific, the Middle East and Africa. America dominates the global medicines market due to the amount it spends on animal welfare and research in the veterinary market.

The report found that a high concentration of the major veterinary hospitals in the developed countries of the Americas - together with good reimbursement rates - are fuelling market growth. It also cites the high buying power of large healthcare players in the US as another major driving force.

In Europe, the second largest market in the world, market growth is led by Germany and France. The report forecasts that Germany will be the fastest growing market over the assessment period owing to its enormous pharmaceutical industry.

Animal-favoured government policies and tax benefits are also major driving forces in the European market, the report notes.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
Applications open for BEVA Back in the Saddle

The British Equine Veterinary Association (BEVA) has opened applications for its 'Back in the Saddle' coaching programme.

The online scheme offers structured group coaching for members wanting to reflect on their career path and regain clarity. Members may be returning to work after leave, uncertain about next steps or reassessing direction.

Attendees will benefit from impartial guidance and practical tools to support their professional development. Members are encouraged to take a 'proactive, future-focused approach' to their careers.

The sessions, taking place on Wednesdays from 7.30pm-9pm, are open to BEVA members with more than five years' experience. The first session takes place on Wednesday, 3 June 2026.

Applications will close on Wednesday, 27 May 2026.